Praxis Precision Medicines

Forecast & Rating21 analysts currently cover Praxis Precision Medicines, with about 90.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $650.00, about 154.4% upside from the current price of $255.50. Price targets range from $188.00 to $1201.00 — a wide spread, showing clear disagreement over just how much Praxis Precision Medicines can rise. Historically, about 21.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Praxis Precision Medicines closely still see room for the stock to rise. Data as of Oct 22, 2026; for reference only and not investment advice.